Specific plasma lipid classes and phospholipid fatty acids indicative of dairy food consumption associate with insulin sensitivity

American Journal of Clinical Nutrition

Volumn 99, Issue 1, 2014, Pages 46-53

  Nestel, Paul John ^a   Straznicky, Nora ^a   Mellett, Natalie Ann ^a   Wong, Gerard ^a   De Souza, David Peter ^b   Tull, Dedreia Lorraine ^b   Barlow, Christopher Kenneth ^a   Grima, Mariee Teresa ^a   Meikle, Peter John ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

1 O ALKYLGLYCERO 3 PHOSPHORYLCHOLINE; FATTY ACID; INSULIN; LIPID; LYSOPHOSPHATIDYLCHOLINE; PHOSPHOLIPID; SPHINGOLIPID;

ADULT; ARTICLE; BLOOD SAMPLING; BODY MASS; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; DAIRY PRODUCT; DIET RESTRICTION; FAT INTAKE; FATTY ACID BLOOD LEVEL; FEMALE; FOOD COMPOSITION; FOOD INTAKE; HOMEOSTASIS MODEL ASSESSMENT OF INSULIN RESISTANCE; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; LINEAR REGRESSION ANALYSIS; LIPID BLOOD LEVEL; LIPIDOMICS; MAJOR CLINICAL STUDY; MALE; MASS FRAGMENTOGRAPHY; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PHOSPHOLIPID BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; WAIST HIP RATIO;

EID: 84891399393     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.113.071712     Document Type: Article

References (36)

1. Maron DJ, Fair JM, Haskell WL. Saturated fat intake and insulin resistance in men with coronary artery disease. Circulation 1991;84: 2020-7.
2. Parker DR, Weiss ST, Troisi R, Cassano PA, Vokonas PS. Relationship of dietary saturated fatty acids and body habitus to serum insulin concentrations: the Normative Aging Study. Am J Clin Nutr 1993;58: 129-36.
3. Vessby B, Unsitupa M, Hermansen K, Riccardi G, Rivelleses AA, Tapsell LC, Nalsen C, Berglund L, Louheranta A, Rasmussen BM, et al. Substituting dietary saturated fat for monounsaturated fat impairs insulin sensitivity in healthy men and women: The KANWU Study. Diabetologia 2001;44:312-9.
4. Mayer-Davis EJ, Monaco JH, Hoen HM, Carmichael S, Vitolins MZ, Rewers MJ, Haffner SM, Ayad MF, Bergman RN, Karter AJ. Dietary fat and insulin sensitivity in a triethnic population: the role of obesity. The Insulin Resitance Atherosclerosis Study (IRAS). Am J Clin Nutr 1997;65:79-87.
5. Black MH, Watanabe RM, Trigo E, Tkayanagi M, Lawrence JM, Buchanan TA, Xiang AH. High-fat diet is associated with obesitymediated insulin resistance in Mexican Americans. J Nutr 2013;143: 479-85.
6. Nestel P. Nutrition and metabolism: the changing face of the dairycardiovascular risk paradox. Curr Opin Lipidol 2012;23:1-3.
7. Lutsey PL, Steffen LM, Stevens J. Dietary intake and the development of the metabolic syndrome: the Atherosclerosis Risk in Communities study. Circulation 2008;117:754-61.
8. Pereira MA, Jacobs DR Jr, Van Horn L, Kartaslow AI, Ludwig DS. Dairy consumption, obesity and the insulin resistance syndrome in young adults: the CARDIA study. JAMA 2002;287:2081-9.
9. Fumeron F, Lamri A, Khalil CA, Jaziri R, Porchay-Balderelli I, Lantieri O, Vol S, Balkau B, Marre M. dairy consumption and the incidence of hyperglycemia and the metabolic syndrome. Diabetes Care 2011;34:813-7.
10. Aune D, Norat T, Romundstad P, Vaaten LJ. Dairy products and the risk of type 2 diabetes: a systematic review and dose-response metaanalysis of cohort studies. Am J Clin Nutr 2013;98:1066-83.
11. Choi HK, Willett WC, Stampfer MJ, Rimm E, Hu FB. Dairy consumption and risk of type 2 diabetes mellitus in men: a prospective study. Arch Intern Med 2005;165:997-1003.
12. Liu S, Choi HK, Ford E, Song Y, Klevak A, Buring JE, Manson JE. A prospective study of dairy intake and the risk of type 2 diabetes in women. Diabetes Care 2006;29:1579-84.
13. Sluijs I, Forouhi NG, Beulens JW, van der Schouw YT, Agnoli C, Arriola A, Balkau B, Barricarte A, Boeing H, Bueno-de-Mesquita HB, et al. The amount and type of dairy product intake and incident type 2 diabetes. Am J Clin Nutr 2012;96:382-90.
14. Mozaffarian D, Cao H, King IB, Lemaitre RN, Song X, Siscovick DS, Hotamisligil G. trans-Palmitoleic acid, metabolic risk factors, and newonset diabetes in U.S. adults. Ann Intern Med 2010;153:790-9.
15. Mozaffarian D, de Oliveirs Otto M, Lemaitre RN, Ftretts AM, Hotamisligil G, Tsai MY, Siscovick DS, Nettleton JA. trans-Palmitoleic acid, other dairy fat markers, and incident diabetes: the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Clin Nutr 2013;97:854-61.
16. Kröger J, Zietermann V, Enzenbach C, Weikert C, Jansen EHJM, Doring F, Joost H-G, Boeing H, Schulze MB. Erythrocyte membrane phospholipid fatty acids, desaturase activity, and dietary fatty acids in relation to type 2 diabetes in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Am J Clin Nutr 2011;93:127-42.
17. Yea K, Kim J, Yoon JH, Kwon T, Kim JH, Lee BD, Lee H-J, Lee SJ, Kim J-I, Lee TG, et al. Lysophosphatidylcholine activates adipocyte glucose uptake and lowers blood glucose levels in marine models of diabetes. J Biol Chem 2009;284:33833-40.
18. Zhao X, Fritsche J, Wang J, Chen J, Rittig K. metabolomic fingerprints of fasting plasma and urine reveals human pre-diabetic metabolic traits. Metabolomics 2010;6:362-74.
19. Barber MN, Ross S, Yang C, Meikle P, Staples M, Febraio M, Bruce CR, Waki H. Plasma lysophosphatidylcholine levels are reduced in obesity and type 2 diabetes. PLoS ONE 2012;7:e41456.
20. Rabini RA, Galassi R, Fumelli P, Dousset N, Solera ML, Valdiguie P, Curatola G, Taus M, Mazzanti L. Reduced Na(+)-ATPase activity and plasma lysophosphatidylcholine concentrations in diabetic subjects. Diabetes 1994;43:915-9.
21. Haus JM, Kashyap SR, Kasumov T, Zhang R, Kelly KR, DeFronzo RA, Kirwan JP. Plasma ceramides are elevated in obese subjects with type 2 diabetes and correlate with the severity of insulin resistance. Diabetes 2009;58:337-43.
22. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association, National Heart, Lung and Blood Institute Scientific Statement. Circulation 2005;112:2735-52.
23. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and b-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-9.
24. Matsuda M, DeFronzo R. Insulin sensitivity indices obtained from oral glucose tolerance testing. Comparison with the euglycemic insulin clamp. Diabetes Care 1999;22:1462-70.
25. Meikle PJ, Wong G, Tsorotes D, Barlow CK, Weir JM, Christopher MJ, Macintosh GL, Goudey B, Stern L, Kowalczk A, et al. Plasma lipidomic analysis of stable and unstable coronary artery disease. Arterioscler Thromb Vasc Biol 2011;31:2723-32.
26. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Royal Stat Soc Series B (Methodol) 1995:289-300.
27. Mozaffarian D, Cao H, King IB, Lemaitre RN, Song X, Siscovick DS, Hotamisligil GS. Circulating palmitoleic acid risk of metabolic abnormalities and new-onset diabetes. Am J Clin Nutr 2010;92:1350-8.
28. Fabbrini E, Magkos F, Su X, Abumrad NA, Nejedly N, Coughlin CC, Okunade AL, Patterson BW, Klein S. Insulin sensitivity is not associated with palmitoleate availability in obese humans. J Lipid Res 2011;52:808-12.
29. Patel PS, Sharp SJ, Jansen E, Luben RN, Khaw KT, Wareham NJ, Forouhi NG. fatty acids measured in plasma and erythrocyte membrane phospholipids and derived by food-frequency questionnaire and the risk of new onset type 2 diabetes; a pilot study in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Norfolk cohort. Am J Clin Nutr 2010;92:1214-22.
30. Han MS, Lim YM, Qan W, Kim JR, Chung KW, Kang M, Kim S, Park SY, Cheon HG, Dai Rhee S, et al. Lysophosphatidylcholine as an effector of fatty acid-induced insulin resistance. J Lipid Res 2011;52:1234-46.
31. Heilbronn LK, Coster ACF, Campbell LV, Greenfield JR, Lange K, Christopher MJ, Meikle PJ, Samocha-Bonet D. The effect of short-term overfeeding on serum lipids in healthy humans. Obesity (Silver Spring) (Epub ahead of print 23 May 2013).
32. Welch EJ, Ram P, Naikawadi RP, Li Z, Lin P, Ishii S, Shimizu T, Tiruppathi C, Du X, Subbiah V, et al. Opposing effects of plateletactivating factor and lyso-platelet-activating factor on neutrophil and platelet activation. Mol Pharmacol 2009;75:227-34.
33. Kudolo GB, Bressler P, DeFronzo RA. Plasma PAF acetylhydrolase in non-insulin diabetes and obesity: effect of hyperinsulinemia and lovastatin treatment. J Lipid Mediat Cell Signal 1997;17:97-113.
34. Serban M, Tanaseanu C, Kosaka T, Vidulescu C, Stoian I, Marta DS, Tanaseanu S, Moldoveanu E. Significance of platelet-activating factor acetylhydrolase in patients with non-insulin-dependent (type 2) diabetes mellitus. J Cell Mol Med 2002;6:643-7.
35. Wang Y, Rimm EB, Stampfer MJ, Willett WC, Hu FB. Comparison of abdominal obesity and overall obesity in predicting risk of type 2 diabetes among men. Am J Clin Nutr 2005;81:555-63.
36. Bray GA, Jablonski KA, Fujimoto WY, Barrett-Connor E, Haffner S, Hanson RL, Hill JO, Hubbard V, Kriska A, Stamm E, et al. Relation of central adiposity and body mass index to the development of diabetes in the Diabetes Prevention Program. Am J Clin Nutr 2008;87:1212-8.